1. Home
  2. GEO vs MIRM Comparison

GEO vs MIRM Comparison

Compare GEO & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEO
  • MIRM
  • Stock Information
  • Founded
  • GEO 1984
  • MIRM 2018
  • Country
  • GEO United States
  • MIRM United States
  • Employees
  • GEO N/A
  • MIRM N/A
  • Industry
  • GEO Homebuilding
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEO Consumer Discretionary
  • MIRM Health Care
  • Exchange
  • GEO Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • GEO 3.7B
  • MIRM 3.3B
  • IPO Year
  • GEO 1994
  • MIRM 2019
  • Fundamental
  • Price
  • GEO $21.85
  • MIRM $74.19
  • Analyst Decision
  • GEO Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • GEO 5
  • MIRM 10
  • Target Price
  • GEO $42.00
  • MIRM $74.20
  • AVG Volume (30 Days)
  • GEO 2.7M
  • MIRM 712.4K
  • Earning Date
  • GEO 11-06-2025
  • MIRM 11-11-2025
  • Dividend Yield
  • GEO N/A
  • MIRM N/A
  • EPS Growth
  • GEO 153.61
  • MIRM N/A
  • EPS
  • GEO 0.63
  • MIRM N/A
  • Revenue
  • GEO $2,452,358,000.00
  • MIRM $429,161,000.00
  • Revenue This Year
  • GEO $7.69
  • MIRM $53.08
  • Revenue Next Year
  • GEO $18.85
  • MIRM $20.45
  • P/E Ratio
  • GEO $34.97
  • MIRM N/A
  • Revenue Growth
  • GEO 1.17
  • MIRM 62.33
  • 52 Week Low
  • GEO $12.29
  • MIRM $36.86
  • 52 Week High
  • GEO $36.46
  • MIRM $78.10
  • Technical
  • Relative Strength Index (RSI)
  • GEO 50.17
  • MIRM 62.63
  • Support Level
  • GEO $20.34
  • MIRM $73.70
  • Resistance Level
  • GEO $23.16
  • MIRM $76.87
  • Average True Range (ATR)
  • GEO 0.74
  • MIRM 2.49
  • MACD
  • GEO 0.28
  • MIRM -0.70
  • Stochastic Oscillator
  • GEO 54.98
  • MIRM 42.28

About GEO Geo Group Inc (The) REIT

The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: